Clinical advances in viral-vectored influenza vaccines

Clinical advances in viral-vectored influenza vaccines

Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate d...

書誌詳細
主要な著者:	Sebastian, S, Lambe, T
フォーマット:	Journal article
出版事項:	MDPI 2018

類似資料

Clinical Advances in Viral-Vectored Influenza Vaccines
著者:: Sarah Sebastian, 等
出版事項: (2018-05-01)

Viral vector vaccines
著者:: McCann, N, 等
出版事項: (2022)

Clinical development of viral vectored vaccines against MERS-COV
著者:: Ewer, K, 等
出版事項: (2018)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
著者:: D. A. Mezhenskaia, 等
出版事項: (2018-12-01)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
著者:: Bissett, C, 等
出版事項: (2024)

Viral vectors as vaccine platforms: from immunogenicity to impact
著者:: Ewer (nee Russell), K, 等
出版事項: (2016)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
著者:: Cameron Bissett, 等
出版事項: (2024-06-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
著者:: Arunkumar, G, 等
出版事項: (2019)

Research advances in replication-deficient viral vector vaccines
著者:: Junna Wang, 等
出版事項: (2025-03-01)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
著者:: McMahon, M, 等
出版事項: (2019)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
著者:: Antrobus, R
出版事項: (2014)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
著者:: Tully, C, 等
出版事項: (2017)

Towards the development of a universal influenza vaccine: investigating viral-vectored vaccine-induced heterosubtypic immune responses to influenza A
著者:: Tully, C
出版事項: (2015)

Evaluating the potential of novel virus-vectored vaccines as intranasal vaccine candidates for broad immunity against influenza
著者:: Mullin, J, 等
出版事項: (2014)

Development of viral vectors for passive immunisation against influenza
著者:: Tan, TK
出版事項: (2017)

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
著者:: Irina Isakova-Sivak, 等
出版事項: (2022-07-01)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
著者:: Marta Ulaszewska, 等
出版事項: (2023-01-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
著者:: Antrobus, R, 等
出版事項: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
著者:: Antrobus, R, 等
出版事項: (2014)

Adenoviral vectors as novel vaccines for influenza.
著者:: Coughlan, L, 等
出版事項: (2015)

Viral vectors for malaria vaccine development.
著者:: Li, S, 等
出版事項: (2007)

The use of viral vectors in vaccine development
著者:: Tatianna Travieso, 等
出版事項: (2022-07-01)

Replicon RNA Viral Vectors as Vaccines
著者:: Kenneth Lundstrom
出版事項: (2016-11-01)

Developments in Viral Vector-Based Vaccines
著者:: Takehiro Ura, 等
出版事項: (2014-07-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
著者:: Ewer (nee Russell), K, 等
出版事項: (2017)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
著者:: Kapulu, MC
出版事項: (2014)

Recombinant influenza A viruses as vaccine vectors
著者:: Thomas Gerlach, 等
出版事項: (2019-04-01)

Viral vectors as vaccine platforms: Deployment in sight
著者:: Rollier, C, 等
出版事項: (2011)

Novel viral vector vaccines for tropical infections
著者:: Rampling, T
出版事項: (2017)

Viral vectors as vaccine platforms: deployment in sight.
著者:: Rollier, C, 等
出版事項: (2011)

Viral Vectors for COVID-19 Vaccine Development
著者:: Kenneth Lundstrom
出版事項: (2021-02-01)

Viral Vector Vaccines against Bluetongue Virus
著者:: Luis Jiménez-Cabello, 等
出版事項: (2020-12-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
著者:: Katie Ewer, 等
出版事項: (2017-12-01)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
著者:: Sushmita Kumari, 等
出版事項: (2022-08-01)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
著者:: Jianfeng Zhang
出版事項: (2012-11-01)

Advances in Adjuvanted Influenza Vaccines
著者:: Shintaro Shichinohe, 等
出版事項: (2023-08-01)

Approaches to quality control, preclinical and clinical studies of live recombinant viral vector vaccines
著者:: L. M. Khantimirova, 等
出版事項: (2021-12-01)

Developing viral vectored vaccines for MAGE-expressing tumours
著者:: McAuliffe, J
出版事項: (2020)

Baculovirus expression vector system for production of viral vaccines /
著者:: 300419 Vlak, J. M., 等

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
著者:: Dulce Mata-Espinosa, 等
出版事項: (2023-10-01)